Global Hemp Group Welcomes Louis Rene Vallee as Business Development Advisor
Vancouver, BC -- (February 21, 2024) -- GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG0) is pleased to welcome Louis René Vallée, President & CEO of Montreal, Québec based Power Food Group to GHG's team as Business Development Advisor. He is a marketing specialist and an expert in brand creation, new product introductions, and positioning of products across retail and wholesale sectors in Canada and the United States.
Mr. Vallee will play a key role is spearheading GHG's business development and marketing efforts for both the Company's Industrial Hemp Division and its Health and Wellness Division. He brings to GHG an impressive network of relationships in the financial, banking and governmental sectors, along with C-Suite contacts to major grocery chains in both Canada and the United States.
Over the years Mr. Vallee has helped analyze markets and created many new products for the companies he represented, as well as assisting early-stage business start-ups to properly guide them in their business development.
Over the past 25 years, Louis Rene, Founder and President of Power Food Group Inc. has specialized in merchandising in the Retail and Food Service sector, including Industrial and Co-packing. In addition to their work in North America, Power Foods has been involved in export sales of products in Asia and Europe. The company also does private label products, provides branding and marketing services, and has a trading division for transactions with other countries. Prior to ownership of his own corporation, Mr. Valle was a senior officer or director of various companies in the food brokerage industry.
About Global Hemp Group Inc.
Global Hemp Group Inc. (CSE: GHG / OTC: GBHPF / FRANKFURT: GHG) is a dynamic company currently focused on two key business segments - Industrial Hemp and Biopharma.
The Industrial Hemp division’s primary focus lies in the environmental uses of hemp for construction and hemp for sustainable bio-energy sources, both contributing to a carbon-negative footprint. Our R&D team is engaged in developing Intellectual Property that can be patented and implemented within our projects and beyond.
The Health and Wellness Division is focused on the acquisition of exclusive patents and IP through licensing agreements. The Company acquired exclusive rights to key patents and IP of Apollon Formularies plc., a UK-based international pharmaceutical company whose formulations and patents specialize in developing cancer treatments from natural biologics, including cannabinoids and functional mushrooms. More recently, the Company has signed a Letter of Intent with B-Organic R&D Corp. relating to the use of their Bioactive Lipid Agents (“BLA”) technology with cannabinoids, terpenes, flavonoids and mushroom extracts. BLA enhances the solubility and bioavailability of various “poorly soluble pharma ingredients”.
These strategic alliances form the basis for the commercialization of promising independently pre-clinically tested formulations, underscoring our commitment to cutting-edge innovation in the commercial biopharma sector.
For Further Information Contact Global Hemp Group
Investor Relations
Tel: 778-726-2900
info@globalhempgroup.com
https://www.globalhempgroup.com
Cautionary Note Regarding Forward Looking Statements
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.